The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Structural basis of substrate discrimination and integrin binding by autotaxin
Open accessAbstract
Autotaxin (ATX, also known as ectonucleotide pyrophosphatase/phosphodiesterase-2, ENPP2) is a secreted lysophospholipase D that generates the lipid mediator lysophosphatidic acid (LPA), a mitogen and chemoattractant for many cell types. ATX-LPA signaling is involved in various pathologies including tumor progression and inflammation. However, the molecular basis of substrate recognition and catalysis by ATX and the mechanism by which it interacts with target cells are unclear. Here, we present the crystal structure of ATX, alone and in complex with a small-molecule inhibitor. We have identified a hydrophobic lipid-binding pocket and mapped key residues for catalysis and selection between nucleotide and phospholipid substrates. We have shown that ATX interacts with cell-surface integrins through its N-terminal somatomedin B–like domains, using an atypical mechanism. Our results define determinants of substrate discrimination by the ENPP family, suggest how ATX promotes localized LPA signaling and suggest new approaches for targeting ATX with small-molecule therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 9,984
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,896
Krissinel, E., & Henrick, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904026460 · Cited by 3,760
Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7
Langer, G., Cohen, S. X., Lamzin, V. S., & Perrakis, A. (2008) · Nature Protocols · doi:10.1038/nprot.2008.91 · Cited by 1,606
Self-citationSolving structures of protein complexes by molecular replacement with Phaser
McCoy, A. J. (2007) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906045975 · Cited by 1,595
The HADDOCK web server for data-driven biomolecular docking
de Vries, S. J., van Dijk, M., & Bonvin, A. M. J. J. (2010) · Nature Protocols · doi:10.1038/nprot.2010.32 · Cited by 1,400
The emerging role of lysophosphatidic acid in cancer
Mills, G. B., & Moolenaar, W. H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1143 · Cited by 1,094
Self-citationUmezu-Goto, M., Kishi, Y., Taira, A., Hama, K., Dohmae, N., Takio, K., Yamori, T., Mills, G. B., Inoue, K., Aoki, J., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204026 · Cited by 929
Tager, A. M., LaCamera, P., Shea, B. S., Campanella, G. S., Selman, M., Zhao, Z., Polosukhin, V., Wain, J., Karimi-Shah, B. A., Kim, N. D., et al. (2008) · Nature Medicine · doi:10.1038/nm1685 · Cited by 823
Tokumura, A., Majima, E., Kariya, Y., Tominaga, K., Kogure, K., Yasuda, K., & Fukuzawa, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205623200 · Cited by 731
Refinement of severely incomplete structures with maximum likelihood in BUSTER–TNT
Blanc, E., Roversi, P., Vonrhein, C., Flensburg, C., Lea, S. M., & Bricogne, G. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904016427 · Cited by 717
The bioactive phospholipid lysophosphatidic acid is released from activated platelets
Eichholtz, T., Jalink, K., Fahrenfort, I., & Moolenaar, W. H. (1993) · Biochemical Journal · doi:10.1042/bj2910677 · Cited by 645
Self-citationStracke, M. L., Krutzsch, H. C., Unsworth, E. J., Arestad, A., Cioce, V, Schiffmann, E., & Liotta, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45911-x · Cited by 590
van Meeteren, L. A., Ruurs, P., Stortelers, C., Bouwman, P., van Rooijen, M. A., Pradère, J. P., Pettit, T. R., Wakelam, M. J. O., Saulnier-Blache, J. S., Mummery, C. L., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02419-05 · Cited by 529
Self-citationInitiation of neuropathic pain requires lysophosphatidic acid receptor signaling
Inoue, M., Rashid, M. H., Fujita, R., Contos, J. J. A., Chun, J., & Ueda, H. (2004) · Nature Medicine · doi:10.1038/nm1060 · Cited by 520
Tanaka, M., Okudaira, S., Kishi, Y., Ohkawa, R., Iseki, S., Ota, M., Noji, S., Yatomi, Y., Aoki, J., & Arai, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605142200 · Cited by 457
Liu, S., Umezu-Goto, M., Murph, M., Lu, Y., Liu, W., Zhang, F., Yu, S., Stephens, L. C., Cui, X., Murrow, G., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.027 · Cited by 385
NPP-type ectophosphodiesterases: unity in diversity
Stefan, C., Jansen, S., & Bollen, M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.08.005 · Cited by 373
Self-citationRegulation and biological activities of the autotaxin–LPA axis
van Meeteren, L. A., & Moolenaar, W. H. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.02.001 · Cited by 353
Self-citationNucleotide Pyrophosphatases/Phosphodiesterases on the Move
Bollen, M., Gijsbers, R., Ceulemans, H., Stalmans, W., & Stefan, C. (2000) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230091169249 · Cited by 277
Self-citationHow vitronectin binds PAI-1 to modulate fibrinolysis and cell migration
Zhou, A., Huntington, J. A., Pannu, N. S., Carrell, R. W., & Read, R. J. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb943 · Cited by 262
Kanda, H., Newton, R., Klein, R., Morita, Y., Gunn, M. D., & Rosen, S. D. (2008) · Nature Immunology · doi:10.1038/ni1573 · Cited by 257
Lysophosphatidic acid (LPA) and its receptors
Noguchi, K., Herr, D., Mutoh, T., & Chun, J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.11.010 · Cited by 235
Gierse, J. K., Thorarensen, A., Beltey, K., Bradshaw‐Pierce, E. L., Cortes-Burgos, L. A., Hall, T., Johnston, A., Murphy, M. N., Nemirovskiy, O. V., Ogawa, S., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.165845 · Cited by 230
Self-citationBoronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation
Albers, H. M. H. G., Dong, A., van Meeteren, L. A., Egan, D. A., Sunkara, M., van Tilburg, E. W., Schuurman, K., van Tellingen, O., Morris, A. J., Smyth, S. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001529107 · Cited by 204
Self-citationLPA1 Receptor Activation Promotes Renal Interstitial Fibrosis
Prade[Combining Grave Accent]re, J.-P., Klein, J., Gre[Combining Grave Accent]s, S., Guigne[Combining Acute Accent], C., Neau, E., Valet, P., Calise, D., Chun, J., Bascands, J.-L., Saulnier-Blache, J.-S. A. A., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020196 · Cited by 202
Inhibition of Autotaxin by Lysophosphatidic Acid and Sphingosine 1-Phosphate
van Meeteren, L. A., Ruurs, P., Christodoulou, E., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413183200 · Cited by 191
Self-citationNam, S. W., Clair, T., Campo, C. K., Lee, H. Y., Liotta, L. A., & Stracke, M. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203263 · Cited by 187
Zalatan, J. G., Fenn, T. D., Brunger, A. T., & Herschlag, D. (2006) · Biochemistry · doi:10.1021/bi060847t · Cited by 164
ATX expression and LPA signalling are vital for the development of the nervous system
Fotopoulou, S., Oikonomou, N., Grigorieva, E. F., Nikitopoulou, I., Paparountas, T., Thanassopoulou, A., Zhao, Z., Xu, Y., Kontoyiannis, D. L., Remboutsika, E., et al. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.01.007 · Cited by 145
The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated Cancer
Lin, S., Wang, D., Iyer, S. S., Ghaleb, A. M., Shim, H., Yang, V. W., Chun, J. J. M., & Yun, C. C. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.002 · Cited by 130
David, M., Wannecq, E., Descôtes, F., Jansen, S., Deux, B., Ribeiro, J., Serre, C., Grès, S., Bendriss‐Vermare, N., Bollen, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009741 · Cited by 127
Self-citationCrystal structures of two human vitronectin, urokinase and urokinase receptor complexes
Huai, Q., Zhou, A., Lin, L., Mazar, A. P., Parry, G. C., Callahan, J. A., Shaw, D. E., Furie, B., Furie, B. C., & Huang, M. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1404 · Cited by 120
Insulin signaling regulating genes: effect on T2DM and cardiovascular risk
Prudente, S., Morini, E., & Trischitta, V. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.215 · Cited by 87
Discovery and Optimization of Boronic Acid Based Inhibitors of Autotaxin
Albers, H. M. H. G., van Meeteren, L. A., Egan, D. A., van Tilburg, E. W., Moolenaar, W. H., & Ovaa, H. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1005012 · Cited by 78
Self-citationKoike, S., Keino‐Masu, K., Ohto, T., Sugiyama, F., Takahashi, S., & Masu, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012716 · Cited by 52
Taghavi, P., Verhoeven, E., Jacobs, J. J. L., Lambooij, J.-P., Stortelers, C., Tanger, E., Moolenaar, W. H., & van Lohuizen, M. (2008) · Oncogene · doi:10.1038/onc.2008.294 · Cited by 40
Self-citationHausmann, J., Christodoulou, E., Kasiem, M. M. A., Marco, V. D., van Meeteren, L. A., Moolenaar, W. H., Axford, D., Owen, R. L., Evans, G., & Anastassis Perrakis, A. (2010) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309110032938 · Cited by 25
Self-citation
Cited by
Cellular function and molecular structure of ecto-nucleotidases
Zimmermann, H., Zebisch, M., & Sträter, N. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9309-4 · Cited by 977
Phospholipase D: Enzymology, Functionality, and Chemical Modulation
Selvy, P. E., Lavieri, R. R., Lindsley, C. W., & Brown, H. A. (2011) · Chemical Reviews · doi:10.1021/cr200296t · Cited by 389
Grams, R. J., Santos, W. L., Scorei, I. R., Abad-García, A., Rosenblum, C. A., Bita, A., Cerecetto, H., Viñas, C., & Soriano-Ursúa, M. A. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00663 · Cited by 377
The versatility of boron in biological target engagement
Diaz, D. B., & Yudin, A. K. (2017) · Nature Chemistry · doi:10.1038/nchem.2814 · Cited by 331
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
Ni, S., Yao, H., Wang, L., Lu, J., Jiang, F., Lu, A., & Zhang, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081683 · Cited by 321
Metadata
- Authors
- Hausmann, J., Kamtekar, S., Christodoulou, E., Day, J. E., Wu, T., Fulkerson, Z., Albers, H. M. H. G., van Meeteren, L. A., Houben, A. J. S., van Zeijl, L., Jansen, S., Andries, M., Hall, T., Pegg, L. E., Benson, T. E., Kasiem, M., Harlos, K., Kooi, C. W. V., Smyth, S. S., Ovaa, H., Bollen, M., Morris, A. J., Moolenaar, W. H., & Perrakis, A.
- Venue
- Nature Structural & Molecular Biology
- Published
- 2011-01-16
- Volume
- 18
- Issue
- 2
- Pages
- 198-204
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- OpenAlex
- W2096597075
- Cited by
- 278
- References
- 41
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.